Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33891472

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Jun 10
First author
Moore KN

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Jun 10;39(17):1833-1838. doi: 10.1200/JCO.21.00571.
    note
    Source null
    related pmid
    33891471
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2021 Jul 20;39(21):2420. doi: 10.1200/JCO.21.01441.
    note
    Source null
    related pmid
    34265225
    relationship
    Erratum in

Authors and identifiers

  1. name
    Moore KN
    type
    Author
  2. name
    Bookman M
    type
    Author
  3. name
    Sehouli J
    type
    Author
  4. name
    Miller A
    type
    Author
  5. name
    Anderson C
    type
    Author
  6. name
    Scambia G
    type
    Author
  7. name
    Myers T
    type
    Author
  8. name
    Taskiran C
    type
    Author
  9. name
    Robison K
    type
    Author
  10. name
    Mäenpää J
    type
    Author
  11. name
    Willmott L
    type
    Author
  12. name
    Colombo N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moore KN
    type
    Author
  2. name
    Bookman M
    type
    Author
  3. name
    Sehouli J
    type
    Author
  4. name
    Miller A
    type
    Author
  5. name
    Anderson C
    type
    Author
  6. name
    Scambia G
    type
    Author
  7. name
    Myers T
    type
    Author
  8. name
    Taskiran C
    type
    Author
  9. name
    Robison K
    type
    Author
  10. name
    Mäenpää J
    type
    Author
  11. name
    Willmott L
    type
    Author
  12. name
    Colombo N
    type
    Author
bibliography ids
  1. nci-bib-6491a12efbf185666381e00d
book metadata
content sha256
42a5f3e44befe5e804ea2876a2306965c1c89a2e74fc1a85026e19e7b71b12b1
document type
citation
dois
  1. 10.1200/JCO.21.00306
electronic publication date
display
2021 Apr 23
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:33891472
immutable id
pubmed:33891472@42a5f3e44befe5e804ea2876a2306965c1c89a2e74fc1a85026e19e7b71b12b1
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
17
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1842-1855
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Jun 10;39(17):1833-1838. doi: 10.1200/JCO.21.00571.
    note
    Source null
    related pmid
    33891471
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2021 Jul 20;39(21):2420. doi: 10.1200/JCO.21.01441.
    note
    Source null
    related pmid
    34265225
    relationship
    Erratum in
outcomes validated
false
pmid
33891472
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
819752695737584be2e3e15d7d009488f3c89a4614c953e36998f5307343abb8
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jun 10
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33891472/
title
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).

Preserved source evidence · Not medical advice